Journal
CANCER LETTERS
Volume 194, Issue 2, Pages 199-208Publisher
ELSEVIER SCI IRELAND LTD
DOI: 10.1016/S0304-3835(02)00707-3
Keywords
telomerase; telomere; p53; epithelial cell; immortalization; senescence; agonescence; conversion; tumor; cancer; oncogenesis; tumorigenesis; tumor suppressor
Categories
Funding
- NCI NIH HHS [CA-24844] Funding Source: Medline
Ask authors/readers for more resources
Human epithelial cells encounter two senescence barriers that enforce a limited proliferative potential. A first barrier is mediated by the retinoblastoma protein, and can be overcome by multiple types of errors, many of which are observed in human cancers. A second, extremely stringent telomere-dependent barrier, is a consequence of repression of telomerase activity. Although relieved by ectopic hTERT expression, the nature of the errors required to overcome this latter barrier during in vivo carcinogenesis have not yet been defined. Attainment of immortality and telomerase reactivation are crucial to human carcinoma development; the derangements responsible for attainment of immortality may be rate-limiting and permissive for further progression to malignancy. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available